We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

19 hedge funds and large institutions have $20.3M invested in Tenax Therapeutics in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,082% more call options, than puts

Call options by funds: $2.41M | Put options by funds: $39K

0% more ownership

Funds ownership: 0% → 0% (+0%)

17% less funds holding

Funds holding: 23 → 19 (-4)

27% less capital invested

Capital invested by funds: $27.9M → $20.3M (-$7.57M)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
19
Holders Change
-4
Holders Change %
-17.39%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
1
Reduced
4
Closed
5
Calls
$2.41M
Puts
$39K
Net Calls
+$2.37M
Net Calls Change
+$1.78M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$939K
2
EAM
EverPoint Asset Management
Connecticut
+$704K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$2.47M
2
SM
Sabby Management
Florida
-$1.64M
3
OM
Opaleye Management
Massachusetts
-$905K
4
CA
Commerzbank Aktiengesellschaft
Germany
-$176K
5
BIT
BlackRock Institutional Trust
California
-$66K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$4.66M – – –
BC
2
Broadfin Capital
New York
$3.84M – – –
SM
3
Sabby Management
Florida
$2.96M -$1.64M -28 -37%
GPP
4
Great Point Partners
Connecticut
$2.16M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.78M -$58.7K -1 -3%
EAM
6
EverPoint Asset Management
Connecticut
$1.46M +$704K +12 +109%
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$975K +$939K +16 New
BBA
8
Baker Bros. Advisors
New York
$819K – – –
Bank of New York Mellon
9
Bank of New York Mellon
New York
$238K – – –
Deutsche Bank
10
Deutsche Bank
Germany
$222K – – –
CA
11
Commerzbank Aktiengesellschaft
Germany
$195K -$176K -3 -50%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$177K – – –
BCM
13
Bourgeon Capital Management
Connecticut
$137K -$58.7K -1 -33%
NFA
14
Nationwide Fund Advisors
Ohio
$137K – – –
BFA
15
BlackRock Fund Advisors
California
$123K – – –
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$73K – – –
Verition Fund Management
17
Verition Fund Management
Connecticut
$63K – – –
Northern Trust
18
Northern Trust
Illinois
$61K – – –
Creative Planning
19
Creative Planning
Kansas
$60K – – –
DADC
20
D.A. Davidson & Co
Montana
$29K – – –
Group One Trading
21
Group One Trading
Illinois
$29K – – –
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$26K – – –
AIM
23
Acrospire Investment Management
Illinois
$20K – – –
CCMINC
24
Cardinal Capital Management Inc (North Carolina)
North Carolina
$20K – – –
WA
25
WFG Advisors
Texas
$12K – – –
1
2

TENX Hedge Fund Activity: Q4 2016 in Review

19 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q4 2016, worth a combined $20.3M — down 27% from $27.9M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of TENX and 1 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $939K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.47M sold.

  • 19 institutional investors held Tenax Therapeutics (TENX) as of Q4 2016, down from 23 in Q3 2016.
  • Funds reported $20.3M of Tenax Therapeutics stock for Q4 2016, down 27% quarter-over-quarter.
  • 1 fund opened new Tenax Therapeutics positions in Q4 2016 and 5 closed out, a net change of -4 holders.
  • The largest Tenax Therapeutics buyer in Q4 2016 was Point72 Asset Management, an estimated $939K added.
  • The largest Tenax Therapeutics seller in Q4 2016 was Armistice Capital, an estimated $2.47M sold.

Based on aggregated 13F filings for Q4 2016.